Evidence map›Paper›PMID 30185635›Full record

ArticleThe Journal of experimental medicine2018

Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity.

Yoshinaga Ito, Orr Ashenberg, Jason Pyrdol, Adrienne M Luoma, Orit Rozenblatt-Rosen, Matan Hofree, Elena Christian, Lucas Ferrari de Andrade, Rong En Tay, Luc Teyton and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Activation pathways that drive CD4Immunological reviews · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HIPs and HIP-reactive T cells.Clinical and experimental immunology · 2019
    Review
  15. Article
  16. Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes.Current opinion in endocrinology, diabetes, and obesity · 2019
    Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Yoshinaga ItoDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-5567-7014
Orr AshenbergBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.ORCID 0000-0002-7802-8834
Jason PyrdolDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA.
Adrienne M LuomaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA.
Orit Rozenblatt-RosenBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Matan HofreeBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Elena ChristianBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.ORCID 0000-0002-5593-0155
Lucas Ferrari de AndradeDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-2137-2271
Rong En TayDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-3647-9271
Luc TeytonDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA.
Aviv RegevBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Stephanie K DouganDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA stephanie_dougan@dfci.harvard.edu.ORCID 0000-0001-7667-5491
Kai W WucherpfennigDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA kai_wucherpfennig@dfci.harvard.edu.ORCID 0000-0002-1829-302X
Harvard University · USBroad Institute · USDana-Farber Cancer Institute · USScripps Research Institute · US

Funding

TCR recognition of MHC class II peptide compexes in multiple sclerosisP01AI045757 · NIAID · DANA-FARBER CANCER INSTITUTE · PI KUCHROO, VIJAY K., LOVE, JOHN CHRISTOPHER · 1999 to 2017
$22.8M
Cancer Immunology Training GrantT32CA207021 · NCI · DANA-FARBER CANCER INST · PI WUCHERPFENNIG, KAI W · 2016 to 2020
$2.4M
NCI NIH HHS T32 CA207021NIAID NIH HHS P01 AI045757
6 · The paper itself

Abstract

A number of autoimmunity-associated MHC class II proteins interact only weakly with the invariant chain-derived class II-associated invariant chain peptide (CLIP). CLIP dissociates rapidly from I-A

Indexed as

Antigen PresentationAutoimmunityAnimalsAntigens, Differentiation, B-LymphocyteCD4-Positive T-LymphocytesGene Knock-In TechniquesHistocompatibility Antigens Class IIMiceMice, Inbred NODMice, TransgenicAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIinvariant chain

Identifiers

PMID30185635
PMCPMC6170167
OpenAlexW2891366641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.